MétaCan
Menu
Back to cohort
Record W2264885989 · doi:10.1186/s13058-016-0671-y

Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2

2016· article· en· W2264885989 on OpenAlexafffund
Valentina Silvestri, Daniel Barrowdale, Anna Marie Mulligan, Susan L. Neuhausen, Stephen B. Fox, Beth Y. Karlan, Gillian Mitchell, Paul A. James, Darcy L. Thull, Kristin K. Zorn, Natalie J. Carter, Katherine L. Nathanson, Susan M. Domchek, Timothy R. Rebbeck, Susan J. Ramus, Robert L. Nussbaum, Olufunmilayo I. Olopade, Johanna Rantala, Sook-Yee Yoon, Maria A. Caligo, Laura Spugnesi, Anders Bojesen, Inge Søkilde Pedersen, Mads Thomassen, Uffe Birk Jensen, Amanda E. Toland, Leigha Senter, Irene L. Andrulis, Gord Glendon, Peter J. Hulick, Evgeny N. Imyanitov, Mark H. Greene, Christian F. Singer, Christine Rappaport, Gero Kramer, Joseph Vijai, Kenneth Offit, Mark E. Robson, Anne Lincoln, Lauren Jacobs, Eva Macháčková, Lenka Foretová, Marie Navrátilová, Petra Vašíčková, Fergus J. Couch, Emily Hallberg, Kathryn J. Ruddy, Priyanka Sharma, Sung‐Won Kim, Manuel R. Teixeira, Pedro Pinto, Marco Montagna, Laura Matricardi, Aðalgeir Arason, Oskar T. Johannsson, Rósa B. Barkardóttir, Anna Jakubowska, Jan Lubiński, Á. Izquierdo, Miguel Ángel Pujana, Judith Balmañà, Orland Dı́ez, Gabriella Ivády, J. Papp, Edith Oláh, Ava Kwong, Heli Nevanlinna, Kristiina Aittomäki, Pedro Pérez Segura, Tom Van Maerken, Bruce Poppe, Kathleen Claes, Claudine Isaacs, Camille Elan, Christine Lasset, Dominique Stoppa‐Lyonnet, Laure Barjhoux, Muriel Belotti, Alfons Meindl, Andrea Gehrig, Christian Sutter, Christoph Engel, Dieter Niederacher, Doris Steinemann, Karin Kast, Norbert Arnold, Raymonda Varon-Mateeva, Dorothea Wand, Andrew K. Godwin, D. Gareth Evans, Debra Frost, Jo Perkins, Julian Adlard, Louise Izatt, Radka Platte, Rosalind A. Eeles, Ute Hamann, Judy E. Garber, Florentia Fostira, George Fountzilas, Barbara Pasini, Giuseppe Giannini, Piera Rizzolo, Antonio Russo, Laura Cortesi, Laura Papi, Liliana Varesco, Domenico Palli, Ines Zanna, Antonella Savarese, Paolo Radice, Siranoush Manoukian, Bernard Peissel, Monica Barile, Bernardo Bonanni, Alessandra Viel, Valeria Pensotti, Stefania Tommasi, Paolo Peterlongo, Jeffrey N. Weitzel, Ana Osório, Javier Benı́tez, Lesley McGuffog, Sue Healey, Anne‐Marie Gerdes, Bent Ejlertsen, Thomas van Overeem Hansen, Linda Steele, Yuan Chun Ding, Nadine Tung, Ramūnas Janavičius, David E. Goldgar, Saundra S. Buys, Mary B. Daly, Anita Bane, Mary Beth Terry, Esther M. John, Melissa C. Southey, Douglas F. Easton, Georgia Chenevix‐Trench, Antonis C. Antoniou, Laura Ottini

Bibliographic record

VenueBreast Cancer Research · 2016
Typearticle
Languageen
FieldMedicine
TopicMale Breast Health Studies
Canadian institutionsJuravinski HospitalJuravinski Cancer CentreLunenfeld-Tanenbaum Research InstituteUniversity of TorontoUniversity Health Network
FundersNational Center for Advancing Translational SciencesEuropean Regional Development FundNational Health and Medical Research CouncilCanadian Institutes of Health Researchlékařská fakulta Univerzity KarlovyFox Chase Cancer CenterNational Institutes of HealthNational Cancer InstituteLiga Portuguesa Contra o CancroFondazione Italiana per la Ricerca sul CancroLeids Universitair Medisch CentrumLietuvos Mokslo TarybaOvarian Cancer Research FundLandspítali HáskólasjúkrahúsIstituto Toscano TumoriLinköpings UniversitetHungarian Scientific Research FundKWF KankerbestrijdingUniversitair Ziekenhuis GentLunds UniversitetNederlandse Organisatie voor Wetenschappelijk OnderzoekMinistero della SaluteRadboud Universitair Medisch CentrumNorway GrantsGeneralitat de CatalunyaSahlgrenska UniversitetssjukhusetBeth Israel Deaconess Medical CenterErasmus Medisch CentrumVrije Universiteit AmsterdamNational Breast Cancer FoundationNational Institute for Health and Care ResearchDavid F. and Margaret T. Grohne Family FoundationNIH Office of the DirectorMinistério da Ciência, Tecnologia e InovaçãoUniversiteit LeidenBreast Cancer Research FoundationUniverzita Karlova v PrazeDeutsches KrebsforschungszentrumCancer AustraliaCancer Center, University of KansasCancerfondenRadboud UniversiteitFundación Mutua MadrileñaMedical Research CouncilUppsala UniversitetMemorial Sloan-Kettering Cancer CenterDr. Ralph and Marian Falk Medical Research TrustKansas Bioscience AuthorityUniversity of California, San FranciscoUniversiteit GentInstitut Català de la SalutUniversity of PennsylvaniaSusan G. Komen for the CureUniversitair Medisch Centrum GroningenIstituto Oncologico VenetoUmeå UniversitetRoyal Marsden NHS Foundation TrustEuropean Social FundUniversity of ChicagoInstituto de Salud Carlos IIIOhio State UniversityU.S. Department of DefenseCancer Research UKAmerican Cancer SocietyEuropean CommissionAssociazione Italiana per la Ricerca sul Cancro
KeywordsSurgical oncologyBreast cancerMedicineOncologyMale breast cancerBRCA2 ProteinInternal medicineCancerMutationPathologyBioinformaticsGermline mutationGeneticsBiologyGene

Abstract

fetched live from OpenAlex

BACKGROUND: BRCA1 and, more commonly, BRCA2 mutations are associated with increased risk of male breast cancer (MBC). However, only a paucity of data exists on the pathology of breast cancers (BCs) in men with BRCA1/2 mutations. Using the largest available dataset, we determined whether MBCs arising in BRCA1/2 mutation carriers display specific pathologic features and whether these features differ from those of BRCA1/2 female BCs (FBCs). METHODS: We characterised the pathologic features of 419 BRCA1/2 MBCs and, using logistic regression analysis, contrasted those with data from 9675 BRCA1/2 FBCs and with population-based data from 6351 MBCs in the Surveillance, Epidemiology, and End Results (SEER) database. RESULTS: Among BRCA2 MBCs, grade significantly decreased with increasing age at diagnosis (P = 0.005). Compared with BRCA2 FBCs, BRCA2 MBCs were of significantly higher stage (P for trend = 2 × 10(-5)) and higher grade (P for trend = 0.005) and were more likely to be oestrogen receptor-positive [odds ratio (OR) 10.59; 95 % confidence interval (CI) 5.15-21.80] and progesterone receptor-positive (OR 5.04; 95 % CI 3.17-8.04). With the exception of grade, similar patterns of associations emerged when we compared BRCA1 MBCs and FBCs. BRCA2 MBCs also presented with higher grade than MBCs from the SEER database (P for trend = 4 × 10(-12)). CONCLUSIONS: On the basis of the largest series analysed to date, our results show that BRCA1/2 MBCs display distinct pathologic characteristics compared with BRCA1/2 FBCs, and we identified a specific BRCA2-associated MBC phenotype characterised by a variable suggesting greater biological aggressiveness (i.e., high histologic grade). These findings could lead to the development of gender-specific risk prediction models and guide clinical strategies appropriate for MBC management.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.002
metaresearch head score (Gemma)0.006
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.019
Threshold uncertainty score0.038

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0020.006
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0030.004
Science and technology studies0.0000.000
Scholarly communication0.0010.000
Open science0.0010.001
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0020.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.121
GPT teacher head0.421
Teacher spread0.300 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations118
Published2016
Admission routes2
Has abstractyes

Explore more

Same venueBreast Cancer ResearchSame topicMale Breast Health StudiesFrench-language works237,207